BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Fang D, Xu J, Luo R. Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review. BMC Cancer 2020;20:1059. [PMID: 33143662 DOI: 10.1186/s12885-020-07568-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Laghezza A, Piemontese L, Brunetti L, Caradonna A, Agamennone M, Loiodice F, Tortorella P. (2-Aminobenzothiazole)-Methyl-1,1-Bisphosphonic Acids: Targeting Matrix Metalloproteinase 13 Inhibition to the Bone. Pharmaceuticals (Basel) 2021;14:85. [PMID: 33498946 DOI: 10.3390/ph14020085] [Reference Citation Analysis]
2 Venetis K, Piciotti R, Sajjadi E, Invernizzi M, Morganti S, Criscitiello C, Fusco N. Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management. Cells 2021;10:1377. [PMID: 34199522 DOI: 10.3390/cells10061377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Russo S, Scotto di Carlo F, Gianfrancesco F. The Osteoclast Traces the Route to Bone Tumors and Metastases. Front Cell Dev Biol 2022;10:886305. [DOI: 10.3389/fcell.2022.886305] [Reference Citation Analysis]